The FDA announced on March 2, 2021, that Azure Biotech is recalling Assure COVID-19 IgG/IgM Rapid Test Devices due to incorrect labeling and unsupported expiration dating. The recall affects approximately 100,000 kits distributed in the U.S., Canada, and worldwide.
How to tell if you have it
- Brand: Azure Biotech
- Product: Assure COVID-19 IgG/IgM Rapid Test Device
- Pouch Label variants: FaStep Rapid Diagnostic Test * Rapid Reliable Simple * COVID-19 IgG/IgM Rapid Test Device (Whole blood/Serum/Plasma) * For Emergency Use Authorization Only; ECOTEST RAPID DIAGNOSTIC TEST * /Rapid / Reliable / Simple/ * COVID-19 IgG/IgM Rapid Test Device (Whole blood/Serum/Plasma) * For Emergency Use Authorization Only
- Box Label variants: FaStep Rapid Diagnostic Test * COVID-19 IgG/IgM Rapid Test Device (Whole blood/Serum/Plasma) * For Emergency Use Authorization Only * For in vitro diagnostic use only; ECOTEST RAPID DIAGNOSTIC TEST * Rapid Reliable Simple * COVID-19 IgG/IgM Rapid Test Device * For Professional in vitro diagnostic use only * For Emergency Use Authorization Only
- Lot Numbers: I2004001, I2004003, I2006128, I2005023, and I2006030
- Quantity: 100,000 kits
- Distribution: U.S. (CA, FL, GA, IL, LA, MD, MN, NC, TX, UT, VA, WA), Canada, Worldwide
The hazard
The devices carry incorrect labeling stating they are "for diagnostic use" and feature an unsupported 24-month expiration date. The FDA said this mislabeling could lead to improper use of the tests.
Context
GovInfoNow's records show Azure Biotech has had prior regulatory issues, including the GET TESTED Biological Age Test distribution without premarket approval on November 3, 2025. Other recent recalls of similar diagnostic products include the Siemens Healthcare Syva EMIT 2000 Quinidine Assay (July 13, 2026) and the Covidien EndoFLIP System (May 13, 2026).